Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–234.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Lortet-Tieulent J, Colombet M, et al. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021;9(3):144–152.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Leboulleux S, Tuttle RM, Pacini F, et al. Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol. 2016;4(11):933–942.
   PubMed Web of Science ®Google Scholar
• Yavuz DG, Yazan CD, Hekimsoy Z, et al. Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients. Clin Endocrinol (Oxf). 2022;97:833–840.
   PubMed Web of Science ®Google Scholar
• Grani G, Ramundo V, Verrienti A, et al. Thyroid hormone therapy in differentiated thyroid cancer. Endocrine. 2019;66(1):43–50.
   PubMed Web of Science ®Google Scholar
• Brancatella A, Marcocci C. TSH suppressive therapy and bone. Endocr Connect. 2020;9(7):R158–R172.
   PubMed Web of Science ®Google Scholar
• Won HR, Jeon E, Chang JW, et al. Is maintaining thyroid-stimulating hormone effective in patients undergoing thyroid lobectomy for low-risk differentiated thyroid cancer? A systematic review and meta-analysis. Cancers (Basel). 2022;14(6):1470.
   PubMed Web of Science ®Google Scholar
• Sugitani I, Ito Y, Takeuchi D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma. Thyroid. 2021;31(2):183–192.
   PubMed Web of Science ®Google Scholar
• Mauri G, Hegedus L, Bandula S, et al. European thyroid association and cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197.
   PubMed Web of Science ®Google Scholar
• Orloff LA, Noel JE, Stack BC, Jr., et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: an international multidisciplinary consensus statement of the American. Head Neck. 2022;44(3):633–660. [Mismatch
   PubMed Web of Science ®Google Scholar
• Park HS, Baek JH, Park AW, et al. Thyroid radiofrequency ablation: updates on innovative devices and techniques. Korean J Radiol. 2017;18(4):615–623.
   PubMed Web of Science ®Google Scholar
• Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130(6):971–977.
   PubMed Web of Science ®Google Scholar
• Xu D, Ge M, Yang A, et al. Expert consensus workshop report: guidelines for thermal ablation of thyroid tumors (2019 edition). J Cancer Res Ther. 2020;16(5):960–966.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang M, Song Q, et al. Ultrasound-guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid. 2021;31(11):1662–1672.
   PubMed Web of Science ®Google Scholar
• Lang BH, Wong KP, Cheung CY, et al. Evaluating the prognostic factors associated with cancer-specific survival of differentiated thyroid carcinoma presenting with distant metastasis. Ann Surg Oncol. 2013;20(4):1329–1335.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618.
   PubMed Web of Science ®Google Scholar
• Baek S, Park SH, Won E, et al. Propensity score matching: a conceptual review for radiology researchers. Korean J Radiol. 2015;16(2):286–296.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Specker B, Ho M, et al. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the national thyroid cancer treatment cooperative registry. Thyroid. 1998;8(9):737–744.
   PubMed Web of Science ®Google Scholar
• McGriff NJ, Csako G, Gourgiotis L, et al. Effects of thyroid hormone suppression therapy on adverse clinical outcomes in thyroid cancer. Ann Med. 2002;34(7–8):554–564.
   PubMed Web of Science ®Google Scholar
• Diessl S, Holzberger B, Mader U, et al. Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma. Clin Endocrinol (Oxf). 2012;76(4):586–592.
   PubMed Web of Science ®Google Scholar
• Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ. 2014;348:g3045.
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Thyroid Carcinoma, Version 1. 2020. [cited 2020 Jun 12]. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp
   Google Scholar
• Kim JH, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632–655.
   PubMed Web of Science ®Google Scholar
• Xu S, Huang Y, Huang H, et al. Optimal serum thyrotropin level for patients with papillary thyroid carcinoma after lobectomy. Thyroid. 2022;32(2):138–144.
   PubMed Web of Science ®Google Scholar
• Park S, Kim WG, Han M, et al. Thyrotropin suppressive therapy for low-risk small thyroid cancer: a propensity Score-Matched cohort study. Thyroid. 2017;27(9):1164–1170.
   PubMed Web of Science ®Google Scholar
• Lee YM, Jeon MJ, Kim WW, et al. Optimal thyrotropin suppression therapy in low-risk thyroid cancer patients after lobectomy. J Clin Med. 2019;8(9):1279.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis. Thyroid. 2020;30(5):720–731.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Chung SM, Kim H, et al. Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: results of a 10-year retrospective study. Thyroid. 2021;31(11):1723–1729.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Wang SR, Che Y, et al. Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: a multicenter retrospective study. Radiology. 2021;300(1):209–216.
   PubMed Web of Science ®Google Scholar
• Yan L, Lan Y, Xiao J, et al. Long-term outcomes of radiofrequency ablation for unifocal low-risk papillary thyroid microcarcinoma: a large cohort study of 414 patients. Eur Radiol. 2021;31(2):685–694.
   PubMed Web of Science ®Google Scholar
• Yue WW, Qi L, Wang DD, et al. US-guided microwave ablation of low-risk papillary thyroid microcarcinoma: longer-Term results of a prospective study. J Clin Endocrinol Metab. 2020;105(6):dgaa128.
   PubMed Web of Science ®Google Scholar
• Brennan MD, Bergstralh EJ, van Heerden JA, et al. Follicular thyroid cancer treated at the Mayo clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clinic Proceedings. 1991;66(1):11–22.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418–428.
   PubMed Web of Science ®Google Scholar